Clinical Trials Logo

Esophageal Diseases clinical trials

View clinical trials related to Esophageal Diseases.

Filter by:

NCT ID: NCT02025244 Recruiting - Clinical trials for Other Specified Disorders of Esophagus, Stomach or Duodenum

EUS-FNA Versus KHB in Diagnostics of Upper Gastrointestinal Submucosal Tumors

Start date: November 2010
Phase: N/A
Study type: Interventional

Upper Gastrointestinal Submucosal Tumors are tumors arising from subepithelial layers of esophageal, gastric or duodenal wall. They usually have an intact mucosa lining on the inner surface. The prognosis and treatment of these tumors depend on their correct diagnostics and mitotic activity in case of Gastrointestinal Stromal Tumors (GIST). A standard forceps biopsy of mucosa is usually not helpful. Therefore, biopsy techniques capable of reaching deeper layer of Upper GUT are needed. The investigators compare KHB and EUS-FNA in the diagnostics of Upper gastrointestinal Submucosal Tumors.

NCT ID: NCT02002078 Completed - Esophageal Diseases Clinical Trials

Caustic Esophageal Burns in Children and High Doses of Methylprednisolone

Start date: February 2007
Phase: Phase 4
Study type: Interventional

Corrosive substance ingestion in childhood is a public health issue in developing countries and several management protocols were proposed to prevent esophageal strictures. The role of corticosteroids in preventing corrosive-induced strictures is controversial. The investigators' aim is to study the influence of high doses of corticosteroids to prevent esophageal strictures.

NCT ID: NCT01927016 Completed - Esophageal Neoplasm Clinical Trials

Outcomes After Esophageal Cancer Surgery

FREGAT I
Start date: July 2012
Phase: N/A
Study type: Observational

Background - Esophageal carcinoma is the sixth leading cause of cancer -related mortality and the eighth most common cancer worldwide - The incidence is increasing rapidly - The overall 5-year survival ranges from 15% to 25% in the literature and poor outcomes are related to diagnosis at advanced stages. - Surgery used to be the cornerstone of treatment of resectable esophageal cancer, but treatment of esophageal carcinoma remains challenging and need to be considered through a multimodal approach. However the modalities and the impact of this multimodal approach at a national level are unknown Primary objective: To identify predictors of recurrence after esophageal cancer surgery Secondary objectives : - 5-year recurrence free survival - 5-year overall survival - Predictors of postoperative mortality and morbidity after surgery - Impact of pCR on recurrence and survival - Impact of neoadjuvant treatments on recurrence and survival - Impact of patient preconditioning (such as nutritional support, esophageal prosthesis, mini-invasive approach…) on outcomes Methodology : European French-speaking retrospective multicentric study Inclusion criteria: All consecutive patients operated on, for a histologically proven carcinoma of the esophagus, the oesophago-gastric junction (Siewert type I and II), in surgical investigator centers between January 2000 and December 2010 Exclusion criteria: Siewert III type carcinoma of the oesophago-gastric junction , non surgical treatment of esophageal carcinoma Planned study period: The data will be collected over a 11-year period from January 2000 to December 2010. Follow up will be ascertained in May 2013.

NCT ID: NCT01438385 Recruiting - Colorectal Cancer Clinical Trials

Interventional Endoscopy Database for Pancreatico-biliary, Gastrointestinal and Esophageal Disorders

Start date: July 2011
Phase: N/A
Study type: Observational

Our institution performs therapeutic ERCP (Endoscopic retrograde cholangiopancreatography ), Endoscopic Ultrasound (EUS) and Interventional Endoscopy in around 1000 patients a year. Procedures such as biliary and/or pancreatic sphincterotomy, stents placement (metallic or plastic) and removal for revision, cysts and pseudocysts drainage are conducted in patients suffering from pancreatico-biliary disorders, gastrointestinal disorders and esophageal disorders. The investigators would like to assess prospectively the efficacy and safety of these routine procedures to permit identification of technical details about the procedures or other factors which might be associated with outcome or results. Assessment of these details would help us with problem identification and recommendations to improve health outcomes and quality of life in these patients.

NCT ID: NCT01360515 Completed - Clinical trials for Gastroesophageal Reflux

A Study of Disposable Transnasal Esophagoscope

Start date: October 2010
Phase: N/A
Study type: Observational

This is a pilot study of a novel disposable transnasal esophagoscope for feasibility, safety and tolerance.

NCT ID: NCT01225523 Completed - Clinical trials for Squamous Carcinoma of Esophagus

Perioperative Vs. Preoperative Chemotherapy With Surgery in the Squamous Carcinoma of Esophagus

Start date: January 1997
Phase: Phase 1
Study type: Interventional

To assess whether or not a perioperative therapy with surgery can improve the outcomes among patients with potentially curable squamous carcinoma of esophagus as compared to a preoperative chemotherapy followed by surgery

NCT ID: NCT01191645 Completed - Clinical trials for Opioid Induced Pharyngeal and Esophageal Dysfunction

Opioid Effects on Swallowing and Esophageal Sphincter Pressure

Start date: October 2010
Phase: Phase 4
Study type: Interventional

The purpose of this study is to determine whether a dopamine receptor antagonist metoclopramide can counteract opioid induced effects on esophageal motility and lower esophageal sphincter. The aim of this study is also to evaluate if the opioid antagonist naloxone reduces the opioid induced pharyngeal and esophageal dysfunction.

NCT ID: NCT01019993 Completed - Lung Diseases Clinical Trials

Non-dependent Lung High Frequency Positive Pressure Ventilation (HFPPV) and Right Ventricular Function

Start date: February 2004
Phase: Phase 1
Study type: Interventional

The investigators hypothesized that the application of volume-controlled HFPPV to the non-dependent lung during one-lung ventilation (OLV) for thoracotomy in patients with good pulmonary functions and mild-to-moderate pulmonary dysfunction may provide preservation of the right ventricular (RV) function, adequate oxygenation and optimum surgical conditions. The investigators evaluated the effects of IL-HFPPV on RV ejection fraction (REF), RV end-diastolic volume (RVEDVI), RV stroke work (RVSWI), pulmonary vascular resistance (PVRI), and stroke volume (SVI) indices, oxygen delivery (DO2) and uptake (VO2), shunt fraction (Qs: Qt), and surgical field conditions during OLV for thoracotomy in patients with good and mild-to-moderate impaired pulmonary functions.

NCT ID: NCT01012960 Completed - Clinical trials for Pharyngeal Dysfunction

Opioids and Esophageal Function

Start date: November 2009
Phase: Phase 4
Study type: Interventional

The purpose of this study is to evaluate if opioid-induced effects on the pharynx and esophagus is centrally or peripherally mediated.

NCT ID: NCT00977678 Completed - Peptic Ulcer Clinical Trials

Drop in Gastroscopy - Experience After 9 Months

Start date: November 2009
Phase: N/A
Study type: Observational

The capacity for endoscopical procedures in the Norwegian health system is low in comparison to demands from patients and family practitioners. The studies aim is to evaluate the acceptance of a new concept: an open access gastroscopy clinic where patients can attend without a preceding appointment. The investigators wish to evaluate: 1. Patient´s satisfaction. 2. General practitioner´s satisfaction. 3. Acceptance by the staff of the clinic.